Recruitment challenges for clinical trials with novel regimens for drug-resistant tuberculosis

Eur Respir J. 2016 Feb;47(2):670-2. doi: 10.1183/13993003.01330-2015. Epub 2015 Dec 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Antitubercular Agents / therapeutic use*
  • Clinical Trials as Topic*
  • Comorbidity
  • Extensively Drug-Resistant Tuberculosis / drug therapy*
  • Extensively Drug-Resistant Tuberculosis / epidemiology
  • Female
  • HIV Infections / epidemiology
  • Humans
  • Male
  • Middle Aged
  • Patient Selection*
  • Tuberculosis, Multidrug-Resistant / drug therapy
  • Tuberculosis, Multidrug-Resistant / epidemiology
  • Tuberculosis, Pulmonary / drug therapy*
  • Tuberculosis, Pulmonary / epidemiology
  • Young Adult

Substances

  • Antitubercular Agents